Medical News

RSS

Genetic variants determine severity of HCV-related graft disease and antiviral treatment response

German researchers have found a significant association of IL28B genotypes to interferon-based antiviral treatment outcome, and to graft inflammation caused by hepatitis C virus (HCV). The study determined that the presence of G-allele serves as a marker for severe HCV-induced graft inflammation, as well as a predictor for unsuccessful treatment. Study findings—the largest to report on the role IL28B variants in a transplant cohort with recurrent HCV—are published in the March issue of Liver Transplantation, a journal of the American Association for the Study of Liver Diseases.

2 Mar 2011

Oxygen Biotherapeutics receives U.S. Army grant for studies of Oxycyte

Oxygen Biotherapeutics, Inc. (NASDAQ and SIX Swiss Exchange: OXBT) today announced it has received a $2,075 million two-year grant from the U.S. Army to study the Company’s proprietary Oxycyte® PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury (TBI).

2 Mar 2011

Health care needs to look to aviation industry to improve safety

In a commentary published today in the Journal of the American Medical Association, a leading patient safety expert argues that failure to integrate new electronic equipment in modern hospital operating rooms and intensive care units results in diagnostic mistakes, failures to identify deteriorating patients, communication errors and inefficient work.

2 Mar 2011

Viruses that are natural part of human genome may retrovirus culprit

A retrovirus that inserted itself into the human genome thousands of years ago may be responsible for some cases of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), also known as Lou Gherig’s disease. The finding, made by Johns Hopkins scientists, may eventually give researchers a new way to attack this universally fatal condition.

2 Mar 2011

Cyberonics third quarter net sales increase 15.3% to $47.1 million

Cyberonics, Inc., a global leader in epilepsy management, today announced results for the quarter ended January 28, 2011.

2 Mar 2011

PreTreat Complete is now available for public to reduce migraine headaches

A new migraine supplement, PreTreat Complete, with active compounds designed to reduce the frequency and intensity of migraine headaches is now available.

2 Mar 2011

Reliv fourth-quarter net sales decrease to $18.5 million

Reliv International, Inc. a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth-quarter and full-year of 2010.

2 Mar 2011

Novabay commences NVC-422 catheter Phase 2 trial to treat UCBE

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing its first-in-class, anti-infective Aganocide compounds for the local non-systemic treatment and prevention of antibiotic-resistant infections, today provided an update on its Phase 2 clinical trial for the use of its lead compound, NVC-422, to prevent urinary catheter blockage and encrustation which is often a contributing factor to urinary tract infections in chronically catheterized patients.

2 Mar 2011

Achillion fourth quarter revenue is $2 million for three months ended December 31, 2010

Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported financial results for the three and twelve months ended December 31, 2010.

2 Mar 2011

Cellastim and Optiferrin enable development of xeno-free and blood product-free expansion media

A recent study demonstrated that Cellastim and Optiferrin deliver superior xeno-free and animal-free solutions for primary cell and stem cell expansion media.

2 Mar 2011

Research: Blocking two cell DNA repair routes at once can provide new way to treat bowel cancer

Cancer Research UK-funded scientists have discovered that blocking two cell DNA repair routes at once could provide a completely new way to treat bowel cancer and potentially other cancers, according to research published in Cancer Research, today.

2 Mar 2011

SCAI statement highlights multiple recommendations for evaluating PCI quality at cardiac facilities

Today the Society for Cardiovascular Angiography and Interventions announced the publication of recommendations for assessing and improving program quality at percutaneous coronary intervention programs at cardiac facilities.

2 Mar 2011

Level 3, ALA sign agreement to provide DIA, voice services to improve lung health awareness

Level 3 Communications, Inc. today announced that it has signed an agreement with the American Lung Association of the Midland States, a non-profit healthcare organization serving Kentucky, Michigan, Ohio and Tennessee, to provide dedicated Internet access and voice services in support of its mission to improve lung health awareness.

2 Mar 2011

Virostatics' VS411 Phase 2a trial results against HIV presented at 18th CROI

An analysis of immune markers measured in a sub-study of ViroStatics' proof-of-concept Phase 2a trial showed that VS411 was able to reduce immune activation while producing a median 1.5 log10 reduction in viral load.

2 Mar 2011

OZ Systems helps TEHDI program to provide latest newborn hearing screening equipment for midwives

OZ Systems today announced that it is helping the Texas Early Hearing Detection and Intervention Program facilitate an initiative that will provide the latest newborn hearing screening equipment to midwives across the state.

2 Mar 2011

Cord Blood America purchases all UCB samples and related lab equipment from RGI

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company, focused on bringing the life saving potential of cord blood stem cells to families nationwide and internationally, announced today that it has purchased all the umbilical cord blood samples and the related laboratory equipment from Reproductive Genetics Institute, Inc., based in Chicago, Illinois.

2 Mar 2011

Avvo launches new medical website for users to make physician search more effective

Avvo, the world's largest online directory for doctors and lawyers that provides free rankings for 90% of the working physicians in the U.S., continues to grow the number of service features offered on its medical website - to bring doctors and patients the latest, breakthrough online directory tools.

2 Mar 2011

Ipsen, Gtx terminate collaboration for development and commercialization of toremifene

GTx, Inc. today announced that the company and Ipsen have mutually agreed to terminate their collaboration for the development and commercialization of toremifene.

2 Mar 2011

NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

The National Eye Institute and Food and Drug Administration are sponsoring a conference to determine how functional vision-related endpoints for clinical trials of visual prostheses will be analyzed and correlated with objective measures of visual acuity, visual fields and contrast sensitivity.

2 Mar 2011

WARFARIN study to explore impact of genetic testing on individualized dosing

Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study was initiated in major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.

2 Mar 2011

Medical News

Genetic variants determine severity of HCV-related graft disease and antiviral treatment response

Oxygen Biotherapeutics receives U.S. Army grant for studies of Oxycyte

Health care needs to look to aviation industry to improve safety

Viruses that are natural part of human genome may retrovirus culprit

Cyberonics third quarter net sales increase 15.3% to $47.1 million

PreTreat Complete is now available for public to reduce migraine headaches

Reliv fourth-quarter net sales decrease to $18.5 million

Novabay commences NVC-422 catheter Phase 2 trial to treat UCBE

Achillion fourth quarter revenue is $2 million for three months ended December 31, 2010

Cellastim and Optiferrin enable development of xeno-free and blood product-free expansion media

Research: Blocking two cell DNA repair routes at once can provide new way to treat bowel cancer

SCAI statement highlights multiple recommendations for evaluating PCI quality at cardiac facilities

Level 3, ALA sign agreement to provide DIA, voice services to improve lung health awareness

Virostatics' VS411 Phase 2a trial results against HIV presented at 18th CROI

OZ Systems helps TEHDI program to provide latest newborn hearing screening equipment for midwives

Cord Blood America purchases all UCB samples and related lab equipment from RGI

Avvo launches new medical website for users to make physician search more effective

Ipsen, Gtx terminate collaboration for development and commercialization of toremifene

NEI/FDA conference to analyze functional vision outcomes from clinical trials of visual prostheses

WARFARIN study to explore impact of genetic testing on individualized dosing

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News